Vor Biopharma is a biopharmaceutical company developing novel therapies with potential for treating cancer. The Company has developed a health and safety commission technology platform to address the limitations of the immunotherapies, including antibody-drug conjugates, bispecific antibodies, and chimeric antigen receptor T cells.
|Employees (est.) (Feb 2019)||5|
Vor Biopharma total Funding
Vor Biopharma latest funding size
Time since last funding
|4 months ago|
Vor Biopharma investors
|5AM Ventures, RA Capital Management, Johnson & Johnson Innovation, Novartis Institutes for Biomedical Research, Johnson & Johnson Innovation – JJDC, OUP (Osage University Partners), Pagliuca Family Office|
When was Vor Biopharma founded?
Vor Biopharma was founded in 2016.
Who are Vor Biopharma key executives?
Vor Biopharma's key executives are Robert Ang, Sadik Kassim and Amy Mendel.
How many employees does Vor Biopharma have?
Vor Biopharma has 5 employees.
Who are Vor Biopharma competitors?
Competitors of Vor Biopharma include DNAtriX, Inhibitor Therapeutics and Dauntless Pharmaceuticals.
Where is Vor Biopharma headquarters?
Vor Biopharma headquarters is located at 215 First St Suite 430, Cambridge.
Where are Vor Biopharma offices?
Vor Biopharma has an office in Cambridge.
How many offices does Vor Biopharma have?
Vor Biopharma has 1 office.
Receive alerts for 300+ data fields across thousands of companies